Hiring IP Associates – Job Openings at BananaIP

BananaIP is seeking qualified Intellectual Property Associates to join its IP Research, Analysis and Advisory Division in Bangalore. Applicants with LLM in IP or BTech/LLB and relevant experience are preferred. The recruitment process includes written tests, interviews, and a review of submitted documents.

Read more about Hiring IP Associates – Job Openings at BananaIP

Supreme Court restores order extending time limits indefinitely, asks why Government is not invoking compulsory licensing provisions and more

The Supreme Court has indefinitely extended limitation periods for legal proceedings in view of the COVID-19 situation and questioned the Government’s approach to compulsory licensing of essential medicines. India also features on the US Special 301 Report’s Priority Watch List, while the USPTO is hosting free design patent webinars.

Read more about Supreme Court restores order extending time limits indefinitely, asks why Government is not invoking compulsory licensing provisions and more

Vitiation of IPAB and Beyond – Changes to the Indian Patents Act

The abolition of the IPAB has shifted appellate and adjudicatory functions under the Indian Patents Act to the High Courts. This post analyses the significant legal changes, outlining the expanded role of Indian High Courts in patent matters after the Tribunals Reforms Ordinance 2021.

Read more about Vitiation of IPAB and Beyond – Changes to the Indian Patents Act

63% more applications granted last week; publications tally at 791

The latest Indian patent statistics show a significant rise in granted applications and publications for the week ending 26th June 2020. The report provides detailed city-wise data, design registrations, and insights from BananaIP Counsels, supporting patent awareness in India.

Read more about 63% more applications granted last week; publications tally at 791

COVID-19 patent pool opposed as Pfizer and AstraZeneca see no incentive and other patent news

This bulletin provides updates on the COVID-19 patent pool, opposition from leading pharmaceutical companies, and key patent law changes in India and abroad. It includes IPO e-filing developments, WHO C-TAP news, and significant international patent infringement cases.

Read more about COVID-19 patent pool opposed as Pfizer and AstraZeneca see no incentive and other patent news

Intellectual Property (IP) Seminar at Cochin, Kerala: Register for Free

The Intellectual Property Seminar in Cochin explores IP value and patent grant strategies for Indian businesses. Sessions led by expert attorneys provide practical insights for technology companies, startups, and inventors.

Read more about Intellectual Property (IP) Seminar at Cochin, Kerala: Register for Free